Altre lingue Mesoblast Limited

Azioni

MSB

AU000000MSB8

Tempo differito Australian S.E. Altri mercati azionari 07:56:51 19/04/2024			Variaz. 5gg	Var. 1 gen.
0,7675 ^AUD	-0,97%		-11,05%	+146,77%

26/03	La FDA afferma che i dati dello studio di Mesoblast sono sufficienti a sostenere la presentazione del BLA	MT
26/03	Aggiornamento settoriale: i titoli del settore sanitario avanzano nel tardo pomeriggio	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

ADRs End Higher; Connect Biopharma Climbs 26%	01/04
ADRs End Lower; NuCana Slides 15%	28/03
Reddit Inc. (NYSE: RDDT) Surges, Uncovering Undervalued Opportunities: DYAI, INBS, MESO, VTAK	28/03
ADRs End Lower; Quhuo Drops 53%	26/03
FDA Says Mesoblast Trial Data Sufficient to Support BLA Submission	26/03
Sector Update: Health Care Stocks Advance Late Afternoon	26/03
Top Midday Gainers	26/03
Sector Update: Health Care Stocks Steady Premarket Tuesday	26/03
Wall Street Set to Open Modestly Higher Tuesday Ahead Consumer Confidence Reading	26/03
Top Premarket Gainers	26/03
Mesoblast Shares Jump After FDA Nod for Submission of Remestemcel-L Application	26/03
Mesoblast to Resubmit Application for Potential Pediatric Treatment of Graft Versus Host Disease; Shares Gain Pre-Bell	26/03
United States Food & Drug Administration (FDA) Notifies Mesoblast that Available Clinical Data from Phase 3 Trial Appear Sufficient to Support BLA Submission for Remestemcel-L in Children with Steroid-Refractory Acute Graft Versus Host Disease (SR-aGVHD)	26/03
United States Food & Drug Administration Notifies Mesoblast Limited of Available Clinical Data from Phase 3 Trial Appear Sufficient to Support BLA Submission for Remestemcel-L in Children with Steroid-Refractory Acute Graft Versus Host Disease	26/03
Mesoblast Limited(ASX:MSB) added to S&P/ASX Emerging Companies Index	18/03
Mesoblast Raises AU$97 Million From Entitlement Offer, Institutional Placement	14/03
Mesoblast Raises AU$97 Million for Phase Three Registration Trials	14/03
Mesoblast Successfully Completes Placement and Accelerated Entitlement Offer	14/03
Sector Update: Health Care Stocks Softer Late Afternoon	11/03
Sector Update: Health Care Stocks Decline in Afternoon Trading	11/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Mesoblast Limited

Azioni

MSB

AU000000MSB8

Altre lingue

Filtri